Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index; 1 of the 8 sources its claims cite were checked for support.
Abstract
To the Editor—We read with interest the article by Wang et al [1] describing the clinical features of 69 patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Wuhan, China. The authors provide a detailed description of major signs and symptoms of overt disease [2, 3], but fail to give an account of minor symptoms that may be present at earlier stages of the infection. After some patients admitted for coronavirus disease 2019 (COVID-19) at the Infectious Disease Department of L. Sacco Hospital in Milan, Italy, complained of olfactory and taste disorders (OTDs), we performed a cross-sectional survey of the prevalence of these alterations in the context of SARS-CoV-2 infection. On 19 March 2020, a simple questionnaire including questions about the presence or absence of OTDs, their type and time of onset respective to hospitalization were submitted through verbal interview to all SARS-CoV-2–positive hospitalized patients who were able to give informed consent. Of 88 hospitalized patients, 59 were able to be interviewed (29 were nonrespondents, of whom 4 had dementia, 2 had a linguistic barrier, and 23 were on noninvasive ventilation) (Table 1). Of these, 20 (33.9%) reported at least 1 taste or olfactory disorder and 11 (18.6%) both. Twelve patients (20.3%) presented the symptoms before the hospital admission, whereas 8 (13.5%) experienced the symptoms during the hospital stay. Taste alterations were more frequently (91%) before hospitalization, whereas after hospitalization taste and olfactory alteration appeared with equal frequency. Females reported OTDs more frequently than males (10/19 [52.6%] vs 10/40 [25%]; P = .036). Moreover, patients with at least 1 OTD were younger than those without (median, 56 years [interquartile range {IQR}, 47–60] vs 66 [IQR, 52–77]; P = .035). All patients reported the persistence of OTDs at the time of the interview. Characteristics of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection Assessed for Taste and Olfactory Disorders (N = 59) Data are presented as no. (%) unless otherwise indicated. Abbreviations: IQR, interquartile range; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. Characteristics of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection Assessed for Taste and Olfactory Disorders (N = 59) Data are presented as no. (%) unless otherwise indicated. Abbreviations: IQR, interquartile range; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. Olfactory and taste disorders are well known to be related with a wide range of viral infections [4, 5]. SARS-CoV has demonstrated in a mice model a transneural penetration through the olfactory bulb [6]. Moreover, angiotensin-converting enzyme 2 receptor, which is used by SARS-CoV-2 to bind and penetrate into the cell, is widely expressed on the epithelial cells of the mucosa of the oral cavity [7]. These findings could explain the underlying pathogenetic mechanism of taste and olfactory disorders in SARS-CoV-2 infection. Due to limitations related to the diffusivity of the disease and emergency contingencies, it was impossible to perform a more structured questionnaire associated with validated tests (ie, Pennsylvania smell identification test) [8]. However, our survey shows that OTDs are fairly frequent in patients with SARS-CoV-2 infection and may precede the onset of full-blown clinical disease. In a pandemic context, further investigations on nonhospitalized infected patients are required to ascertain if these symptoms, albeit unspecific, may represent a clinical screening tool to orientate testing of pauci-symptomatic individuals. Acknowledgments. The authors thank all patients enrolled in the cohort and all medical staff (paramedics, nurses, and physicians) who began this fight on one side of the wall and eventually fell ill during the battle. The authors also thank Tiziana Formenti and Bianca Ghisi for their excellent and indefatigable technical help. Potential conflicts of interest. A. G. has received consultancy fees from Mylan and nonfinancial support from Gilead. S. R. and C. G. have received grants and fees for speaker’s bureaus, advisory boards, and continuing medical education (CME) activities from Bristol-Myers Squibb (BMS), ViiV, Merck Sharp & Dohme (MSD), AbbVie, Gilead, and Janssen. M. G. and G. R. have received grants and fees for speaker’s bureaus, advisory boards, and CME activities from BMS, ViiV, MSD, AbbVie, Gilead, Janssen, and Roche. S. A. has received support for research activities from Pfizer and MSD. All other authors report no potential conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Overview
CoChat Summary
TL;DR
In a cross-sectional survey of 59 hospitalized SARS-CoV-2-positive patients in Milan, 20 (33.9%) reported at least one olfactory or taste disorder, and 11 (18.6%) reported both. The authors conclude these symptoms were fairly frequent and could precede full-blown disease, but they were assessed with a simple self-report questionnaire rather than validated smell/taste tests.
Key findings
- Of 88 hospitalized patients, 59 were interviewed; among them, 20 (33.9%) reported at least 1 taste or olfactory disorder, and 11 (18.6%) reported both.
- Twelve patients (20.3%) reported symptoms before hospital admission, while 8 (13.5%) experienced them during the hospital stay; taste alterations were more frequent before hospitalization (91%), whereas after hospitalization taste and olfactory alterations appeared with equal frequency.
- Patients with at least 1 olfactory/taste disorder were younger than those without: median 56 years (IQR 47–60) vs 66 years (IQR 52–77), P = .035.
- Females reported OTDs more frequently than males (10/19 [52.6%] vs 10/40 [25%], P = .036). All patients reported persistence of OTDs at the time of interview.
Methods
- Cross-sectional survey conducted on 19 March 2020 at the Infectious Disease Department of L. Sacco Hospital in Milan, Italy.
- Participants were 59 SARS-CoV-2-positive hospitalized patients who were able to give informed consent, out of 88 hospitalized patients total.
- A simple verbal questionnaire assessed presence/absence of olfactory and taste disorders, symptom type, and timing relative to hospitalization; results were summarized descriptively with reported P values for comparisons.
Limitations
- The paper explicitly states that, due to disease diffusivity and emergency contingencies, it was impossible to use a more structured questionnaire with validated tests such as the Pennsylvania smell identification test.
- The sample was limited to hospitalized, interviewable patients; 29 of 88 hospitalized patients were nonrespondents, including 4 with dementia, 2 with a linguistic barrier, and 23 on noninvasive ventilation.
- Evident from the text: the study is cross-sectional and self-reported, so it cannot establish causality or objective measurement of olfactory/taste dysfunction.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 Valid · 1 Not valid · 4 Not checked · 9 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“angiotensinconverting enzyme 2 receptor, which is used by SARS-CoV-2 to bind and penetrate into the cell, is widely expressed on the epithelial cells of the mucosa of the oral cavity [7].”
What the sources say
- Partly supportedcites [7] Xu, 2020, High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa, Int J Oral Sci sourceExperimental — accuracy not yet measured
Our copy supports the core attribution: the Abstract states ACE2 is the main host cell receptor of 2019-nCoV and mediates viral entry, and the Results (Single cell RNA-seq analysis of oral tissues) show ACE2 expressed on the mucosa of oral cavity and 'highly enriched in epithelial cells, of which 93.38% ACE2-positive cells belong to epithelial cells'. What the source does not support is the sweeping 'widely expressed' across the oral mucosa: the same Results report only 0.52% ACE2-positive cells overall with 95.86% of them located in oral tongue and lower levels in buccal and gingival tissues, and the Public bulk RNA-seq section notes the tongue-versus-other-sites difference was not significant (P = 0.062). The Discussion also frames these as transcriptomic, preliminary findings requiring histological confirmation, whereas the citing sentence states them as established fact. (LLM, conf=0.72)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of these, 20 (33.9%) reported at least 1 taste or olfactory disorder and 11 (18.6%) both.”
plainn = 59- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“patients with at least 1 OTD were younger than those without (median, 56years [interquartile range {IQR}, 47-60] vs 66 [IQR, 52-77]; P = .035).”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of these, 20 (33.9%) reported at least 1 taste or olfactory disorder and 11 (18.6%) both.”
plainn = 59- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, our survey shows that OTDs are fairly frequent in patients with SARS-CoV-2 infection and may precede the onset of full-blown clinical disease.”
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 2 assumptions not shown here.
2 more claims
Create a free account to see all 15 claims and to verify the 7 references still open.
- Probably not a substantial claim. 5
- It may state two separate claims as one. 4
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Clinical reports suggest that infection with CoV-2 is associated with high rates of disturbances in smell and taste perception, including anosmia (8-13).”
From Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia (2020) · cites this paper as [9]
Experimental — accuracy not yet measured
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
(2020) · PubMed · doi:10.3760/cma.j.issn.0254-6450.2020.02.003 · Cited by 3,323
CDC Weekly, C., & The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team (2020) · China CDC Weekly · doi:10.46234/ccdcw2020.032 · Cited by 2,889
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
Xu, H., Zhong, L., Deng, J., Peng, J., Dan, H., Zeng, X., Li, T., & Chen, Q. (2020) · International Journal of Oral Science · doi:10.1038/s41368-020-0074-x · Cited by 2,838
Doty, R. L., Shaman, P., & Dann, M. (1984) · Physiology & Behavior · doi:10.1016/0031-9384(84)90269-5 · Cited by 1,854 · cited 1×
“Pennsylvania smell identification test) [8].”
Netland, J., Meyerholz, D. K., Moore, S., Cassell, M., & Perlman, S. (2008) · Journal of Virology · doi:10.1128/jvi.00737-08 · Cited by 1,293
The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team (2020) · PubMed Central · Cited by 1,278
Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China
Wang, Z., Yang, B., Li, Q., Wen, L., & Zhang, R. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa272 · Cited by 1,063 · cited 2×
“We read with interest the paper by Wang et al [1] describing the clinical features of 69 patients with Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) infection in Wuhan, China.”
MethodInfluentialvan Riel, D., Verdijk, R., & Kuiken, T. (2015) · The Journal of Pathology · doi:10.1002/path.4461 · Cited by 394
Allis, T. J., & Leopold, D. A. (2012) · Facial Plastic Surgery Clinics of North America · doi:10.1016/j.fsc.2011.10.011 · Cited by 163
Cited by
Characteristics of SARS-CoV-2 and COVID-19
Hu, B., Guo, H., Zhou, P., & Shi, Z.-L. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00459-7 · Cited by 5,291
Nervous system involvement after infection with COVID-19 and other coronaviruses
Wu, Y., Xu, X., Chen, Z., Duan, J., Hashimoto, K., Yang, L., Liu, C., & Yang, C. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.03.031 · Cited by 2,046
“It is therefore likely that anosmia and dysgeusia might be observed in patients with COVID-19 (Giacomelli et al., 2020; Ryan, 2020; Hopkins and Kumar, 2020).”
BackgroundVaratharaj, A., Thomas, N., Ellul, M. A., Davies, N. W. S., Pollak, T. A., Tenorio, E. L., Sultan, M., Easton, A., Breen, G., Zandi, M., et al. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30287-x · Cited by 1,246
Brann, D. H., Tsukahara, T., Weinreb, C., Lipovsek, M., Van den Berge, K., Gong, B., Chance, R., Macaulay, I. C., Chou, H.-J., Fletcher, R. B., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc5801 · Cited by 1,198
Zubair, A. S., McAlpine, L. S., Gardin, T., Farhadian, S., Kuruvilla, D. E., & Spudich, S. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.2065 · Cited by 923
Metadata
- Authors
- Giacomelli, A., Pezzati, L., Conti, F., Bernacchia, D., Siano, M., Oreni, L., Rusconi, S., Gervasoni, C., Ridolfo, A. L., Rizzardini, G., Antinori, S., & Galli, M.
- Affiliations
- University of Milan (IT)
- III Infectious Diseases Unit, Azienda Socio-Sanitaria Territoriale-Fatebenefratelli-Sacco, Milan, Italy
- University of the Witwatersrand (ZA)
- Corresponding author
- Giacomelli, Andrea
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-03-26
- Volume
- 71
- Issue
- 15
- Pages
- 889-890
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC7184514
- OpenAlex
- W3013488343
- Semantic Scholar
- fac013b0a238555cfef7294d49983178a25e0a08
- Cited by
- 1,326
- References
- 12
- Citations by year
- 2026: 7 · 2025: 18 · 2024: 47 · 2023: 121 · 2022: 188 · 2021: 403 · 2020: 540
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Topics
- Life Sciences › Neuroscience › Sensory Systems › Olfactory and Sensory Function Studies
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Dermatology › Dermatological and COVID-19 studies
- Keywords
- COVID-19 pandemic, SARS-CoV-2, olfactory dysfunction, taste disorders, anosmia, ageusia, prevalence, hospitalized patients, symptom onset, sex differences, age differences, persistent symptoms, minor symptoms, Milan, Wuhan
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, China, Cross-Sectional Studies, Humans, Pneumonia, Viral, Taste Disorders, Coronavirus, Coronavirus Infections, Self Report, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. https://app.cochat.ai/papers/10.1093/cid/ciaa330
- The paper
- Giacomelli, A., Pezzati, L., Conti, F., Bernacchia, D., Siano, M., Oreni, L., Rusconi, S., Gervasoni, C., Ridolfo, A. L., Rizzardini, G., Antinori, S., & Galli, M. (2020). Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaa330
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.